Importance of hypercoagulability over hyperglycemia for vascular complication in type 2 diabetes.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8227(00)00134-0PMID 10808060
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Glycemic Control and Blood Pressure in the Development and Progression of Nephropathy in Elderly Japanese NIDDM Patients

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• RISK FACTORS DETERMINING MORTALITY IN OLDER DIABETICS: A PILOT STUDY IN JAPANESE PATIENTS

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Diminished Fibrinolysis in Diabetes Mellitus and its Implication for Diabetic Vascular Disease

  1997cited by this paper
• Increased prothrombin fragment 1+2 and D-dimer in first-degree relatives of type 2 diabetic patients

  1996cited by this paper
• Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria.

  1995cited by this paper
• Pathogenesis of macrovascular disease in diabetes.

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Possible Link Between a Low Prevalence of Cardiovascular Disease and Mild Dyslipidaemia: a Study in Japanese Patients with Type 2 Diabetes

  1993cited by this paper
• Rapid quantitative evaluation of plasma D-dimer levels in thrombotic states using an automated latex photometric immunoassay.

  1992cited by this paper
• Prothrombin fragment 1 + 2, thrombin–antithrombin III complexes and D‐dimers in acute deep vein thrombosis: effects of heparin treatment

  1991cited by this paper
• Dipyridamole reduces urinary albumin excretion in diabetic patients with normo- or microalbuminuria.

  1990cited by this paper
• High Blood Pressure as Risk Factor in Diabetic Retinopathy Development in NIDDM Patients

  1987cited by this paper
• Factors of the hemostatic system in diabetic patients. A survey of controlled studies.

  1986cited by this paper
• Joslin's Diabetes Mellitus

  1971cited by this paper
• Immunohistochemical studies in diabetic glomerulosclerosis.

  1966cited by this paper
• THE BLOOD COAGULABILITY IN DIABETIC PATIENTS.

  1963cited by this paper

• Retinal Vessel Analysis and Microvascular Abnormalities in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms

  2024cites this paper
• Prediction of prognosis in patients with ischemic stroke combined with type 2 diabetes mellitus based on serum total bilirubin levels

  2024cites this paper
• Effect of new oral anticoagulants on microcirculation in ischemic diabetic foot ulcer

  2022cites this paper
• Assessment of coagulation and fibrinolytic factors among patients with type 2 diabetes mellitus in University of Ilorin Teaching Hospital, Ilorin, Nigeria

  2021cites this paper
• Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues

  2021influential citation
• Shenkang Injection protects against diabetic nephropathy in streptozotocin (STZ)-induced mice through enhancement of anti-oxidant and anti-inflammatory activities

  2020cites this paper
• Tannins and vascular complications of Diabetes: An update.

  2019cites this paper
• Effect of poor glycaemic control on plasma levels and activity of protein C, protein S, and antithrombin III in type 2 diabetes mellitus

  2019cites this paper
• Astaxanthin attenuated thrombotic risk factors in type 2 diabetic patients

  2019cites this paper
• Correlation Between Vitreous Advanced Glycation End Products, and D-dimer with Blood HbA1c Levels in Proliferative Diabetic Retinopathy.

  2018cites this paper
• Correlation of Glycated Hemoglobin and D-dimer in Diabetic Patient

  2018cites this paper
• Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) in Type 2 Diabetes Mellitus, a Case Control Study

  2018cites this paper
• Active nano/microbilayer hemostatic agents for diabetic rat bleeding model.

  2017cites this paper
• Measurement of Plasma Von Willebrand Factor Antigen Level among Sudanese Patients with Type 2 Diabetes Mellitus

  2017cites this paper
• A community-based lifestyle intervention program for adults with type 2 diabetes mellitus in a low socio-economic status community

  2016cites this paper
• Asiatic acid and maslinic acid protected heart via anti-glycative and anti-coagulatory activities in diabetic mice.

  2015cites this paper
• Anti-Diabetic Effects of Madecassic Acid and Rotundic Acid

  2015cites this paper
• Coagulation State in Diabetic Retinopathy in Type 2 Diabetic Sudanese Patients

  2015cites this paper
• Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients

  2015cites this paper
• Tyrosine kinase inhibitors modulate platelet function in vitro, ex vivo and in vivo

  2015cites this paper
• The Association Between Type 2 Diabetes Mellitus and Stroke, Coronary Artery Disease and Thromboembolism

  2015cites this paper
• PLATELET ACTIVATION AND ASSOCIATED TRANSCRIPTIONAL SIGNATURE IN TYPE 2 DIABETIC PATIENTS WITH STABLE CORONARY ARTERY DISEASE: INSIGHTS INTO THEIR THROMBOTIC PROPENSITY.

  2014cites this paper
• High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications.

  2014cites this paper
• Mechanisms of cardiovascular disease in the metabolic syndrome and type 2 diabetes mellitus : focus on adverse intermediate phenotypes

  2013cites this paper
• Impact of diabetes and prediabetes on the short-term prognosis in patients with acute ischemic stroke.

  2013cites this paper
• Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation--the Hoorn Study.

  2012cites this paper
• Anticoagulatory and antiinflammatory effects of astaxanthin in diabetic rats.

  2012cites this paper
• REDUCED SERUM HOMOCYSTEINE LEVELS IN DIABETIC PATIENTS

  2012cites this paper
• Hemostatic changes in patients with type 2 diabetes mellitus

  2011influential citation
• The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria

  2011cites this paper
• PAI-1 and D-Dimer in Type 2 Diabetic Women With Asymptomatic Macrovascular Disease Assessed by Carotid Doppler

  2010cites this paper
• Chapter 42. Cerebrovascular Disease

  2010cites this paper
• Anticoagulatory, antiinflammatory, and antioxidative effects of protocatechuic acid in diabetic mice.

  2009cites this paper
• Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice

  2009cites this paper
• Lipoproteína (a) em pacientes portadores de doença arterial obstrutiva periférica e/ou diabetes mellitus tipo 2

  2008cites this paper
• Plasma levels of soluble platelet glycoprotein V are linked to fasting blood glucose in patients with type 2 diabetes

  2008cites this paper
• Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.

  2007cites this paper
• Generall Overview and outline of the thesis

  2007cites this paper
• Coagulation and inflammation in diabetes mellitus

  2007cites this paper
• Coagulation and inflammation in diabetes mellitus

  2007cites this paper
• Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers

  2007cites this paper
• Plasma Total Homocysteine Levels and Methylenetetrahydrofolate Reductase Gene Polymorphism in Patients with Type 2 Diabetes Mellitus

  2007cites this paper
• The recent finding that tissue factor is produced by the pancreatic islets constitutes a possible link between insulin resistance and cardiovascular disease.

  2005cites this paper
• Correlação entre os níveis plasmáticos de apolipoproteínas A-I e B e o perfil lipídico em indivíduos com e sem diabetes mellitus tipo 2 e hipertensão arterial

  2005cites this paper
• Diabetes mellitus und das Gerinnungssystem

  2005cites this paper
• Avaliação da incidência das mutações G1691A no gene do fator V (fator V Leiden) e G20210A no gene da protrombina em pacientes com diabetes mellitus tipo 2

  2005cites this paper
• Five cysteine-containing compounds delay diabetic deterioration in Balb/cA mice.

  2004cites this paper
• Identification of variations of gene expression of visceral adipose and renal tissue in type 2 diabetic rats using cDNA representational difference analysis.

  2003cites this paper
• Diabetes mellitus type 2 and angina pectoris : novel insights in diagnosis, prognosis and treatment

  2002cites this paper
• Niveles de fibrinógeno en plasma en pacientes con diabetes mellitus tipo 2, con infecciones y otras enfermedades intercurrentes

  2002cites this paper
• Effect of the postprandial state on nontraditional risk factors.

  2001cites this paper